U.S. Market for Drug-Eluting & Bare Metal Stents 2009

U.S. Market for Drug-Eluting & Bare Metal Stents 2009 published by iData Research Inc. in May, 2009. This report consists of 65 Pages and the price starts from US $ 3995.

Introduction

Abstract

In 2008, the U.S. market for drug eluting stents was valued at $1.95 billion, representing an increase of 1.6% over 2007. Overall average selling prices are predicted to decrease over the forecast period. Additional products included in this report: Bioabsorbable Stents, Bifurcated Stentsand bare-metal stents.

Table of Contents

U.S. MARKET FOR DRUG-ELUTING AND BARE METAL STENTS 2009

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

• 1.1 MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
• 1.2 BARE-METAL AND DRUG-ELUTING STENTS
• 1.3 PTCA AND CUTTING BALLOONS
• 1.4 BALLOON-INFLATION SYRINGES AND ANGIOPLASTY KITS
• 1.5 INTERVENTIONAL CATHETERS
• 1.6 INTERVENTIONAL GUIDEWIRES
• 1.7 EMBOLIC PROTECTION DEVICES
• 1.8 ATHERECTOMY DEVICES
• 1.9 THROMBECTOMY DEVICES
• 1.10 CHRONIC TOTAL OCCLUSION CROSSERS
• 1.11 INTRODUCER SHEATHS
• 1.12 VASCULAR CLOSURE DEVICES
• 1.13 DIAGNOSTIC CORONARY CATHETERS AND GUIDEWIRES
• 1.14 FRACTIONAL FLOW RESERVE GUIDEWIRES
• 1.15 IVUS CATHETERS
• 1.16 OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES
• 1.17 VULNERABLE PLAQUE DEVICES
• 1.18 PFO, ASD AND VSD DEVICES
• 1.19 PERCUTANEOUS MITRAL VALVE REPAIR DEVICES
• 1.20 AORTIC HEART VALVE REPLACEMENT DEVICES
• 1.21 LEADING COMPETITORS

RESEARCH METHODOLOGY

• 2.1 RESEARCH SCOPE
• 2.2 IDATA' S 9-STEP METHODOLOGY
  • 2.2.1 Step 1: Project Initiation & Team Selection
  • 2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
  • 2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
  • 2.2.4 Step 4: Performing Primary Research
  • 2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
  • 2.2.6 Step 6: Market Forecast and Analysis
  • 2.2.7 Step 7: Identify Strategic Opportunities
  • 2.2.8 Step 8: Final Review and Market Release
  • 2.2.9 Step 9: Customer Feedback and Market Monitoring

BARE-METAL AND DRUG-ELUTING STENTS

• 3.1 INTRODUCTION
• 3.2 POPULATION AT RISK
• 3.3 PROCEDURE NUMBERS
• 3.4 MARKET ANALYSIS & FORECAST
  • 3.4.1 Units Sold by Type
  • 3.4.2 Bare-Metal Stent Market
    • 3.4.2.1 Bare-Metal Stent Market Drivers
    • 3.4.2.2 Bare-Metal Stent Market Limiters
  • 3.4.3 Drug-Eluting Stent Market
    • 3.4.3.1 Drug-Eluting Stent Market Drivers
    • 3.4.3.2 Drug-Eluting Stent Market Limiters
  • 3.4.4 Stents in Development
    • 3.4.4.1 Bioabsorbable Stents
    • 3.4.4.2 Bifurcated Stents
• 3.5 STENT MARKET BY DELIVERY PLATFORM
• 3.6 STENT MARKET BY SIZE
• 3.7 COMPETITIVE ANALYSIS
  • 3.7.1 Bare-Metal Stents
  • 3.7.2 Drug-Eluting Stents
  • 3.7.3 Potential New Market Participants

ABBREVIATIONS

LIST OF FIGURES

• EXECUTIVE SUMMARY
• RESEARCH METHODOLOGY
• BARE-METAL AND DRUG-ELUTING STENTS
• Figure 4-1: Population at Risk, Market for Interventional Cardiology, U.S., 2005- 2015
• Figure 4-2: Angiography and Angioplasty Procedures, U.S., 2005 - 2015
• Figure 4-3: Market for Coronary Stents by Type, U.S., 2005 - 2015
• Figure 4-4: Units Sold, Market for Coronary Stents, U.S., 2005 - 2015
• Figure 4-5: Coronary Stent Units by Type, U.S., 2005 - 2015
• Figure 4-6: Market for Bare-Metal Stents, U.S., 2005 - 2015
• Figure 4-7: Market Drivers and Limiters, Market for Bare-Metal Stents, U.S., 2008
• Figure 4-8: Market for Drug-Eluting Stents, U.S., 2005 - 2015
• Figure 4-9: Market Drivers and Limiters, Market for Drug-Eluting Stents, U.S., 2008
• Figure 4-10: Coronary Stent Platforms in Development Not Approved by the FDA, 2008
• Figure 4-11: Potential Market for Bioabsorbable Stents, U.S., 2013 - 2015
• Figure 4-12: Potential Market for Bifurcated Stents, U.S., 2010 - 2015
• Figure 4-13: Market for Coronary Stents by Delivery Platform, Units Sold, U.S., 2005 - 2015
• Figure 4-14: Market for Coronary Stents by Size, U.S., 2008
• Figure 4-15: Leading Competitors, Market for Bare-Metal Stents, U.S., 2008
• Figure 4-16: Leading Competitors, U.S. Market for Drug-Eluting Stents, 2008
• ABBREVIATIONS

LIST OF CHARTS

• EXECUTIVE SUMMARY
• Chart 1-1: Market for Interventional Cardiology Devices, U.S., 2008
• Chart 1-2: Market for Coronary Stents, U.S., 2005 - 2015
• Chart 1-3: Coronary Atherectomy Devices Market, U.S., 2005 - 2015
• Chart 1-4: Coronary CTO Crosser Market, U.S., 2005 - 2015
• Chart 1-5: Coronary Vascular Closure Devices, U.S., 2005 - 2015
• Chart 1-6: Market for Diagnostic Coronary Catheters and Guidewires, U.S., 2005 - 2015
• Chart 1-7: Penetration Rate of FFR Guidewires in PCI Procedures, U.S., 2005 2015
• Chart 1-8: Number of IVUS Catheter Units Sold, U.S., 2005 - 2015
• Chart 1-9: Optical Coherence Tomography Catheter Market, U.S., 2010 - 2015
• Chart 1-10: Leading Competitors, Market for Interventional Cardiology, U.S., 2008
• RESEARCH METHODOLOGY
• BARE-METAL AND DRUG-ELUTING STENTS
• Chart 4-1: Population at Risk, Market for Interventional Cardiology, U.S., 2005 - 2015
• Chart 4-2: Age Group Most Likely to Undergo Cardiac Intervention: 60 to 69 Years Old, U.S., 2005 - 2015
• Chart 4-3: Angioplasty and Angiography Procedures, U.S., 2005 - 2015
• Chart 4-4: Market for Coronary Stents by Type, U.S., 2005 - 2015
• Chart 4-5: Coronary Stent Units by Type, U.S., 2005 - 2015
• Chart 4-6: Market for Bare-Metal Stents, U.S., 2005 - 2015
• Chart 4-7: Market for Drug-Eluting Stents, U.S., 2005 - 2015
• Chart 4-8: Penetration Rate for Bioabsorbable Stents, U.S., 2013 - 2015
• Chart 4-9: Penetration Rate for Bifurcated Stents, U.S., 2010 - 2015
• Chart 4-10: Market for Coronary Stents by Delivery Platform, Units Sold, U.S., 2005 - 2015
• Chart 4-11: Market for Coronary Stents by Size, U.S., 2008
• Chart 4-12: Leading Competitors, Market for Bare-Metal Stents, U.S., 2008
• Chart 4-13: Leading Competitors, Market for Drug-Eluting Stents, U.S., 2008
• ABBREVIATIONS

Related Reports